EMA Advises Use Of AbCellera-Discovered Bamlanivimab, Alone Or Together With Etesevimab, To Treat...
TheStreet.com· 3 hours agoAbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for bamlanivimab ...
EMA's Medicinal Committee Backs Eli Lilly's COVID-19 Antibody Therapy
Benzinga· 5 hours agoEuropean Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for Eli Lilly and Co's...
Biotech Stock Roundup: REGN, VIR's COVID-19 Updates, KMPH's Drug Approval & More
Zacks via Yahoo Finance· 1 day agoThe biotech sector continues to be in focus with the development of antibodies and vaccines for...
Innovent Announces First Patient Outside China Dosed In The Phase 1 Clinical Trial Of...
TheStreet.com· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology ...
Swapping alpha cells for beta cells to treat diabetes
EurekAlert!· 5 days agoBlocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes...
San Diego startup DTx Pharma raises $100M for platform to treat rare diseases
U-T San Diego· 4 days agoDTx Pharma, a 15-employee San Diego biotechnology company pursuing a platform for creating RNA-based...
Lilly (LLY) announces additional doses of neutralizing antibody therapy purchased by U.S. government...
StreetInsider· 6 days agoThe U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly< ...
Eli Lilly's Tirzepatide Tops Novo's Semaglutide In Late-Stage Diabetes Study
Benzinga· 1 day agoEli Lilly & Co (NYSE: LLY) has reported positive results from another Phase 3 trial evaluating tirzepatide in Type 2 diabetics. The dual GIP/GLP-1 agonist beat Novo Nordisk A/S’s (NYSE: NVO) ...
Eli Lilly (LLY) Stock Moves -0.72%: What You Should Know
Zacks via Yahoo Finance· 1 day agoWith this in mind, we can consider positive estimate revisions a sign of optimism about the...
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron,...
Benzinga via Yahoo Finance· 1 day agoNASDAQ: ICPT) Karyopharm Therapeutics Inc (NASDAQ: KPTI) Lucira Health Inc (NASDAQ: LHDX) Protara...
Yahoo Web Search
Top News Videos for ELI LILLY AND COMPANY
Trending Now
